The temporal trend analyses in both key outcome indicators (rate of com- plete susceptibility and prevalence of ESBL-/AmpC-producers in E. coli) showed an encouraging progress in reducing AMR in food-producing animals in several EU MSs over the last 7 years.
For animals and meat thereof, AMR data on indicator commensal Escherichia coli, presumptive extended-spectrum beta-lactamases (ESBL)-/AmpC beta-lactamases (AmpC)−/carbapenemase (CP)- producing E. coli, and the occurrence of methicillin-resistant Staphylococcus aureus (MRSA) are also analysed. Generally, resistance levels differed greatly between re- porting countries and antimicrobials. Resistance to commonly used antimicrobials was frequently found in Salmonella and Campylobacter isolates from humans and animals. In humans, increasing trends in resistance to one of two critically anti- microbials (CIA) for treatment was observed in poultry-associated Salmonella se- rovars and Campylobacter, in at least half of the reporting countries. Combined resistance to CIA was however observed at low levels except in some Salmonella serovars and in C. coli from humans and animals in some countries. While CP- producing Salmonella isolates were not detected in animals in 2021–2022, nor in 2021 for human cases, in 2022 five human cases of CP-producing Salmonella were reported (four harbouring blaOXA-48 or blaOXA-48-like genes). The reporting of a number of CP-producing E. coli isolates (harbouring blaOXA-48, blaOXA-181, blaNDM-5 and blaVIM-1 genes) in fattening pigs, cattle under 1 year of age, poultry and meat thereof by a limited number of MSs (5) in 2021 and 2022, requires a thorough fol- low-up. The temporal trend analyses in both key outcome indicators (rate of com- plete susceptibility and prevalence of ESBL-/AmpC-producers in E. coli) showed an encouraging progress in reducing AMR in food-producing animals in several EU MSs over the last 7 years.
Source: https://www.ecdc.europa.eu/
List
Add
Please enter a comment